Corporate commotion


The likely direction of future regulation for the over-the-counter (OTC) derivatives market is causing ructions among some major corporates, which are concerned they may face higher hedging charges. These higher costs, they argue, could restrict their ability to do business and have a negative effect on the real economy.

Corporations are worried because policy-makers plan to introduce higher capital charges for counterparties engaging in bespoke OTC derivatives transactions than for similar trad

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: